Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-03-30 Purchase |
2021-04-01 4:15 pm |
Design Therapeutics Inc. | DSGN | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Cormorant Private Healthcare Fund III LP Former 10% Owner |
750,000 | $20 | $15,000,000 | 5,114,844 (Indirect) |
View |
| 2021-03-16 Purchase |
2021-03-18 4:43 pm |
Prometheus Biosciences Inc. | RXDX | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Former 10% Owner |
375,000 | $19 | $7,125,000 | 2,223,022 (Indirect) |
View |
| 2020-11-23 Purchase |
2020-11-23 4:59 pm |
Olema Pharmaceuticals Inc. | OLMA | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Cormorant Private Healthcare Fund III LP Former 10% Owner |
425,000 | $19 | $8,075,000 | 3,270,544 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-03-30 Conversion |
2021-04-01 4:15 pm |
N/A N/A |
Design Therapeutics Inc. | DSGN | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Cormorant Private Healthcare Fund III LP Former 10% Owner |
8,729,688 | $0 | 5,114,844 (Indirect) |
View |
Ownership |
2021-03-25 5:11 pm |
N/A N/A |
Design Therapeutics Inc. | DSGN | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Cormorant Private Healthcare Fund III LP 10% Owner |
0 | $0 | 4,364,844 (Indirect) |
View |
| 2021-03-16 Conversion |
2021-03-18 4:43 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Former 10% Owner |
3,696,045 | $0 | 2,223,022 (Indirect) |
View |
Ownership(A) |
2021-03-18 4:41 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP 10% Owner |
0 | $0 | 1,848,022 (Indirect) |
View |
Ownership |
2021-03-11 5:17 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP 10% Owner |
0 | $0 | 18,480,245 (Indirect) |
View |
| 2020-11-23 Conversion |
2020-11-23 4:59 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Cormorant Private Healthcare Fund III LP Former 10% Owner |
5,691,088 | $0 | 3,270,544 (Indirect) |
View |
Ownership |
2020-11-18 5:09 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Cormorant Private Healthcare Fund III LP 10% Owner |
0 | $0 | 2,845,544 (Indirect) |
View |